Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial

Author(s): Alexander, M; Collins, I; Abraham, P; Underhill, C; Harris, S; Torres, J; Sharma, S; Solomon, B; Tran-Duy, A; Burbury, K;
Details: Publication Year 2023-12,Volume 53,Issue #12,Page 2346-2349
Journal Title: Internal Medicine Journal
Publication Type: Research article
Abstract: This cost analysis, from a societal perspective, compared the cost difference of a networked teletrial model (NTTM) with four regional hubs versus conventional trial operation at a single metropolitan specialist centre. The Australian phase 3 cancer interventional randomised controlled trial included 152 of 328 regional participants (patient enrolment 2018-2021; 6-month primary end point). The NTTM significantly reduced (AU$2155 per patient) patient travel cost and time and lost productivity.
Publisher: Wiley
Keywords: Humans; Australia/epidemiology; *Telemedicine; Costs and Cost Analysis; *Neoplasms/epidemiology/therapy; Medical Oncology; Cost-Benefit Analysis; cancer; clinical trial; cost analysis; patient cost; teletrial
Department(s): Pharmacy; Medical Oncology; Clinical Haematology
Publisher's Version: https://doi.org/10.1111/imj.16292
Open Access at Publisher's Site: https://doi.org/10.1111/imj.16292
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2024-01-16 04:29:24

Last Modified: 2024-01-16 04:53:14